Tarsus market cap

Author: wgzw

August undefined, 2024

WebAccording to Tarsus Pharmaceuticals 's latest financial reports the company has $0.21 B in cash and cash equivalents. A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has. Tarsus Pharmaceuticals - Cash on Hand chart (from 2024 to 2024) WebMarket Cap Revenue; Medical: Medical - Biomedical and Genetics: $0.327B: $0.026B: Tarsus Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutic candidates to address ophthalmic conditions. The company's product candidate consist TP-03 which is in clinical stage.

Tarsus Pharmaceuticals Stock Price Today (NASDAQ: …

WebFeb 5, 2024 · Tarsus Pharmaceuticals, Inc. Market Cap as of today is 433.7 M. Compare the current Market Cap against historical performance and benchmark the TARS Market … WebApr 10, 2024 · Pharmaceuticals & Biotech Tarsus Pharmaceuticals NasdaqGS:TARS Stock Report Last Price US$11.92 Market Cap US$318.6m 7D -8.7% 1Y -29.9% Updated 27 … lysosomes are found in plant or animal cell

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by …

WebGet the latest Tarsus Pharmaceuticals, Inc. (TARS) stock news and headlines to help you in your trading and investing decisions. ... Market open. Advertisement. Summary; … WebDec 2, 2024 · Tarsus Stock Analysis Notes. About 13.0% of the company outstanding shares are owned by corporate insiders. The book value of Tarsus PharmaceuticalsI was at this time reported as 7.6. The company has Price/Earnings To Growth (PEG) ratio of 0.28. Tarsus PharmaceuticalsInc recorded a loss per share of 2.15. WebFeb 7, 2024 · "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted … kiss clip art free

TARS Tarsus Pharmaceuticals Inc. Stock Overview (U.S.: …

Investors Overview Tarsus Pharmaceuticals

WebTarsus PharmaceuticalsI Market Capitalization is currently at 367.28 M. Market Capitalization is the total market value of Tarsus PharmaceuticalsI's equity. It is one of … WebApr 5, 2024 · TARS has a market cap or net worth of $335.22 million as of April 6, 2024. Its market cap has decreased by -7.51% in one year. Market Cap 335.22M Enterprise … lysosomes are known as cleaner of the cellWebTarsus Pharmaceuticals market cap history and chart from 2024 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the … lysosomes are present in all eukaryotic cells

"WebTarsus Pharmaceuticals Inc (TARS) Try Excel Alerts Watch Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market Capitalization, $K 387,011 Shares Outstanding, K 26,672 Annual Sales, $ 57,030 K Annual Income, $ -13,830 K 60-Month Beta 0.59 Price/Sales 6.81 Price/Cash Flow N/A … " - Tarsus market cap

Tarsus market cap

Tarsus Pharmaceuticals, Inc. (TARS) - Yahoo Finance

WebMar 13, 2024 · $14.26 Fair Value Price $42.51 Market Cap $380.35M 52 Week Low $10.80 52 Week High $19.66 P/E -5.13x P/B 1.88x P/S 28.26x PEG N/A Dividend Yield N/A … WebMay 2, 2024 · Tarsus Pharmaceuticals ( NASDAQ: TARS) closed down more than 23% Monday after the company said it would raise $50M in a stock offering earlier in the day. On Monday, Tarsus ( TARS) also announced ...

Did you know?

WebGet the latest Tarsus Pharmaceuticals Inc (TARS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. WebMar 28, 2024 · Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by Assenagon Asset Management S.A. - MarketBeat S&P 500 3,977.53 DOW 32,432.08 QQQ 308.76 Should You Buy Before the Ex-Dividend Date or Wait? BREAKING: Tiny biotech successfully treats blindness (Ad) Dividends, Short-Term Pain, but Long-Term Gain?

WebApr 6, 2024 · Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. WebHC Wainwright & Co. Reiterates Buy on Tarsus Pharmaceuticals, Maintains $40 Price Target - Tarsus Pharmaceuticals ... 10 hours ago Financials Income Statement …

WebApr 6, 2024 · Tarsus Pharmaceuticals Inc. U.S.: Nasdaq Watchlist after hours $ 12.57 TARS 0.00 0.00% Apr 6, 2024 4:01 p.m. EDT After Hours Vol. 1.65K Price at close $ 12.57 0.34 2.78% Apr 6, 2024 4:00 p.m. EDT... WebApr 12, 2024 · According to analysts' consensus price target of $41.00, Tarsus Pharmaceuticals has a forecasted upside of 226.2% from its current price of $12.57. …

WebMar 31, 2024 · See the latest Tarsus Pharmaceuticals Inc Ordinary Shares stock price (NASDAQ:TARS), related news, valuation, dividends and more to help you make your …

WebMar 31, 2024 · IRVINE, Calif., March 31, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to focus on unmet needs and apply... kiss clip art imagesWebAccording to Tarsus Pharmaceuticals 's latest financial reports the company's current revenue (TTM) is $25.81 M . In 2024 the company made a revenue of $57.02 M an increase over the years 2024 revenue that were of N/A .The revenue is the total amount of income that a company generates by the sale of goods or services. lysosomes arise from what organelleWebOperating Margin for Tarsus Pharmaceuticals (TARS) Operating Margin as of March 2024 (TTM): -315.61% According to Tarsus Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -315.61% . At the end of 2024 the company had an Operating Margin of -24.15% . lysosomes assemble proteins in the cellWebTARS - Tarsus Pharmaceuticals Inc Stock quote - CNNMoney.com Video Tarsus Pharmaceuticals Inc (NASDAQ:TARS) 12.68 Delayed Data As of Mar 30 -0.08 / -0.63% Today’s Change 10.80 Today 52-Week... lysosomes as a cityWebTARS - Tarsus Pharmaceuticals, Inc. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Daily Draw Fullscreen Settings TARS - Stock Price Chart TARS [NASD] Tarsus Pharmaceuticals, Inc. kiss clocksWebTarsus Pharmaceuticals Inc (NASDAQ:TARS) 12.68 Delayed Data As of Mar 30 -0.08 / -0.63% Today’s Change 10.80 Today 52-Week Range 19.66 -13.51% Year-to-Date … lysosomes are used by cells to kiss clear nail gel